MBI Incubator at 55 Union Street

MBI’s Union St Labs offer excellent chemistry based facilities along with extensive shared equipment access. The former Charles River Labs has now been re-developed to accommodate several small, established Biotech related companies.

Tenants at the Union Street Labs

Janus Biotherapeutics, Inc.

Website: http://www.janusbio.com/
Contacts:

Joseph Baron, CEO
E-mail: jbaron@janusbio.com

Grayson Lipford, President & CSO
E-mail: glipford@janusbio.com

Charles Zepp, VP Chemistry
E-mail: czepp@janusbio.com

Phone: 1-781-705-3024

Janus Biotherapeutics is an autoimmunity therapeutics company dedicated to the development of novel, orally available compounds for the treatment of autoimmune diseases including systemic lupus erythematosus, rheumatoid arthritis, Sjogren’s syndrome, psoriasis, and scleroderma.

Matrigen Life Technologies
Website: www.matrigen.com
Contact: Justin Mih, Sc.D., CEO
E-mail: justin@matrigen.com
Phone: 508-755-5070

Matrigen Life Technologies objective is to make cell culture more real and keep it simple. We are developing innovative methods to replicate the elasticity of the body’s soft tissues in standard dishes and multiwell plates for routine, cost-effective control of cellular fate and phenotype.

VivoPath
Contact: Walter Lunsmann, M.S., MBA, Co-Founder and Chief Operating Officer

Website: http://www.vivopath.com/
Email: wlunsmann@vivopath.com
Phone: 508-751-5000

VivoPath – delivering in vivo proof-of-concept

VivoPath is a preclinical services company, offering our clients discovery and development services for in vivo testing. VivoPath was established in November of 2008 in Worcester, Massachusetts to support the Massachusetts Life Sciences community.

VivoPath provides integrated in vivo studies and supporting services. Client directed in vivo studies range from pharmacokinetic and pharmacodynamic evaluations to proof-of-concept efficacy to safety and tolerability studies. Supporting services include formulation development, hematology and clinical chemistry analysis, and biomarker assays.

VivoPath’s commitment is to provide scientific expertise in in vivo drug discovery in order to increase productivity from research into drug development.